Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$988,758
+$503,904 QoQ
Shares Held
73,025
-9.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#152
of 626 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. OGN ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $988,758 | 73,025 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $484,854 | 80,944 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $315,358 | 43,983 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $670,906 | 62,819 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,538,315 | 158,917 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $10,707,471 | 719,105 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,196,537 | 616,390 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $8,586,250 | 448,837 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,519,366 | 508,182 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,188,169 | 116,392 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,697,968 | 117,751 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,996,652 | 2,476,766 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $100,253,167 | 4,817,548 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $111,157,890 | 4,726,101 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $95,166,806 | 3,407,333 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $40,092,740 | 1,713,365 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,282,229 | 1,400,955 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $47,303,041 | 1,354,224 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,530,355 | 1,002,639 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,943,898 | 852,208 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||